A gene of rare effect

被引：29

作者：

Hall, Stephen S. ^{[1
]}

机构：

[1] NYU, New York, NY 10003 USA

来源：

NATURE | 2013年 / 496卷 / 7444期

关键词：

TARGET GENES; PCSK9; HYPERCHOLESTEROLEMIA; MICE; CHOLESTEROL; MUTATIONS; ANTIBODY; LIVER; SREBP;

D O I：

10.1038/496152a

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

[No abstract available]

引用

页码：152 / 155

页数：4

共 14 条

[1] Mutations in PCSK9 cause autosomal dominant hypercholesterolemia [J].

Abifadel, M ;

Varret, M ;

Rabès, JP ;

Allard, D ;

Ouguerram, K ;

Devillers, M ;

Cruaud, C ;

Benjannet, S ;

Wickham, L ;

Erlich, D ;

Derré, A ;

Villéger, L ;

Farnier, M ;

Beucler, I ;

Bruckert, E ;

Chambaz, J ;

Chanu, B ;

Lecerf, JM ;

Luc, G ;

Moulin, P ;

Weissenbach, J ;

Prat, A ;

Krempf, M ;

Junien, C ;

Seidah, NG ;

Boileau, C .

NATURE GENETICS, 2003, 34 (02) :154-156

[2] Low LDL cholesterol in African Americans resulting from frequent nonsense mutations in PCSK9 [J].

Cohen, J ;

Pertsemlidis, A ;

Kotowski, IK ;

Graham, R ;

Garcia, CK ;

Hobbs, HH .

NATURE GENETICS, 2005, 37 (03) :328-328

[3] Sequence variations in PCSK9, low LDL, and protection against coronary heart disease [J].

Cohen, JC ;

Boerwinkle, E ;

Mosley, TH ;

Hobbs, HH .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (12) :1264-1272

[4] Multiple rare Alleles contribute to low plasma levels of HDL cholesterol [J].

Cohen, JC ;

Kiss, RS ;

Pertsemlidis, A ;

Marcel, YL ;

McPherson, R ;

Hobbs, HH .

SCIENCE, 2004, 305 (5685) :869-872

[5] PCSK9: a convertase that coordinates LDL catabolism [J].

Horton, Jay D. ;

Cohen, Jonathan C. ;

Hobbs, Helen H. .

JOURNAL OF LIPID RESEARCH, 2009, 50 :S172-S177

[6] Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes [J].

Horton, JD ;

Shah, NA ;

Warrington, JA ;

Anderson, NN ;

Park, SW ;

Brown, MS ;

Goldstein, JL .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (21) :12027-12032

[7] Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 as monotherapy in patients with hypercholesterolaemia (MENDEL): a randomised, double-blind, placebo-controlled, phase 2 study [J].

Koren, Michael J. ;

Scott, Rob ;

Kim, Jae B. ;

Knusel, Beat ;

Liu, Thomas ;

Lei, Lei ;

Bolognese, Michael ;

Wasserman, Scott M. .

LANCET, 2012, 380 (9858) :1995-2006

[8] Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype [J].

Maxwell, KN ;

Breslow, JL .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (18) :7100-7105

[9] Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mice [J].

Maxwell, KN ;

Soccio, RE ;

Duncan, EM ;

Schayek, E ;

Breslow, JL .

JOURNAL OF LIPID RESEARCH, 2003, 44 (11) :2109-2119

[10] Implication of the proprotein convertase NARC-1/PCSK9 in the development of the nervous system [J].

Poirier, Steve ;

Prat, Annik ;

Marcinkiewicz, Edwige ;

Paquin, Joanne ;

Chitramuthu, Babykumari P. ;

Baranowski, David ;

Cadieux, Benoit ;

Bennett, Hugh P. J. ;

Seidah, Nabil G. .

JOURNAL OF NEUROCHEMISTRY, 2006, 98 (03) :838-850

← 1 2 →